Inherited variation in hormone-regulating genes and prostate cancer survival.

Inherited variation in hormone-regulating genes and prostate cancer survival. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Inherited variation in hormone-regulating genes and prostate cancer survival. Abstract Text:

Sara ,Hans-Olov Adami,Katarina Augustsson ,Jianfeng Xu,S Lilly Zheng, Stattin,Henrik ,Fredrik Wiklund,

PURPOSE: Hormonal manipulation is the mainstay treatment of prostate cancer, notably in advanced stages. Despite initial favorably response, the cancer eventually develops hormone resistance resulting in disease progression and death. However, little is known about genetic determinants of disease progression and prostate cancer-specific death. EXPERIMENTAL DESIGN: We analyzed a population-based cohort comprising 2,761 men diagnosed with prostate cancer from March 2001 to October 2003 and with complete follow-up through July 2006. During a median follow-up time of 3.8 years, a total of 300 men had died from prostate cancer. We genotyped 23 haplotype tagging single nucleotide polymorphisms in the genes AR, CYP17, and SRD5A2 and used Cox proportional hazards analyses to quantify associations between genotype and risk of dying from prostate cancer. RESULTS: The variant 'A' allele of an AR promoter single nucleotide polymorphism, rs17302090, was borderline associated with a 50% increased risk of dying from prostate cancer (95% confidence interval, 1.0-2.3; P = 0.07). This finding was more pronounced in patients who received hormonal therapy as primary treatment at diagnosis (hazard ratio, 1.9; 95% confidence interval, 1.3-2.9; P = 0.007). We did not identify any associations between CYP17 or SRD5A2 variation and prostate cancer-specific death. CONCLUSIONS: Our results suggest that inherited genetic variation in the androgen receptor gene affects hormonal treatment response and ultimately prostate cancer death.

Inherited variation in hormone-regulating genes and prostate cancer survival. Publishing Authors By Initials

S ,HO Adami,KA ,J Xu,SL Zheng,P Stattin,H ,F Wiklund,

For similar genetic phenomena: variation (genetics) research abstracts see: genetic phenomena: variation (genetics) research

PUBMED ID PMID:

MEDLINE DATE:

Inherited variation in hormone-regulating genes and prostate cancer survival. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Clinical cancer research : an official journal of

VOLUME: 13

Page Numbers: 5156-61

Journal Abbreviation: Clin. Cancer Res.

ISSN: 1078-0432

DAY: 1

MONTH: Sep

YEAR: 2007

Inherited variation in hormone-regulating genes and prostate cancer survival. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9502500

Inherited variation in hormone-regulating genes and prostate cancer survival. Keywords Mesh Terms:

KEYWORDS: Variation (Genetics)

MESH TERMS: genetics

Chemical & Substance for Abstract: Inherited variation in hormone-regulating genes and prostate cancer survival. Information

Substance Name: Testosterone 5-alpha-Reductase

Registry Number: EC 1.3.99.5

Grant and Affiliation Information for Inherited variation in hormone-regulating genes and prostate cancer survival.

AFFILIATION: Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden. sara.lindstrom@oc.umu.se .

Country: United States

AGENCY: United States NCI

GRANT: CA 105055

ACRONYM: CA

MEDLINETA: Clin Cancer Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Inherited variation in hormone-regulating genes and prostate cancer survival Related Publications

• Accounting for the effect of GERD symptoms on patients' health-related quality of life: supporting optimal disease management by primary care physicians.
• Acute arterial occlusion.
• Acute effects on heart rate variability when exposed to hand transmitted vibration and noise.
• Can analysis of heart rate variability predict arrhythmia in children with fontan circulation?
• Can heart rate variability become a screening tool for anesthesia-related hypotension?
• EFFECT OF FAT EMULSIONS ON NITROGEN BALANCE IN THE POSTOPERATIVE PERIOD.
• Electrocardiographic studies during and after delivery. I. Preliminary report.
• Experience with elective coniotomy.
• Fetal ECG-recording.
• Fetal and neonatal ECG. Studies during labour and after delivery.
• Further studies on the spontaneous course of cervical precancerous conditions.
• Galvanically induced body sway in the anterior-posterior plane.
• Glucose balance and muscle glycogen during TPN in the early post-operative phase.
• Inherited variation in hormone-regulating genes and prostate cancer survival.
• Mating success of resident versus non-resident males in a territorial butterfly.
• Post-operative substrate utilisation and gas exchange using two different TPN-systems: Glucose versus fat.
• Projections from the medial septum and diagonal band of Broca to the dorsal and central superior raphe nuclei: a non-cholinergic pathway.
• Proposal of the Swedish Government Committee for Reform of the Care of Inebriates.
• Psychometric validation of the German translation of the Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire in patients with reflux disease.
• Psychometric validation of the italian translation of the gastrointestinal symptom-rating scale and quality of life in reflux and dyspepsia questionnaire in patients with gastro-oesophageal reflux disease.
• Quality of life and regulatory issues.
• Quality of life: a reflection of symptoms and concerns.
• Release of protein as well as activity of MMP-9 from unstable atherosclerotic plaques during percutaneous coronary intervention.
• Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease.
• Sliding esophageal hiatal hernia with a follow-up study.
• Stomach rupture following ingestion of sodium bicarbonate.
• Symptom overlap in patients with upper gastrointestinal complaints in the Canadian confirmatory acid suppression test (CAST) study: further psychometric validation of the reflux disease questionnaire.
• Treatment of muscle-invasive bladder cancer.
• Wavelet Coherence Detects Non-autonomic Heart Rate Fluctuations in Familial Amyloidotic Polyneuropathy.
• Wireless system for real-time recording of heart rate variability for home nursing.